secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2022-01-25T23:59:59+00:00
Accession:  0001104659-22-007397
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptar appoints Gael Touya as President of Pharma Segment; board classes rebalanced
--------------------------------------------------------------------------------

- Effective Jan 1, 2022, Gael Touya appointed President of Pharma Segment, reporting to CEO Stephan Tanda.
- Touya will be based in Congers, NY, on a 3-year assignment (max 5 years).
- Compensation includes expatriate benefits: housing, car, education, travel, tax equalization.
- His French employment contract with Aptar Europe Holding SAS suspended for assignment duration.
- Board rebalanced classes after death of director Joanne Smith; Candace Matthews shifted to 2023 term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/0001104659-22-007397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/tm224376d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-007397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer